About Gavis Pharmaceuticals
Gavis Pharmaceuticals is a Healthcare company based in Somerset (United States) founded in 2008, and was acquired by Lupin Pharmaceuticals in July 2015. Turf management products are manufactured and supplied for sports turf. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Gavis Pharmaceuticals was founded in 2008 in Somerset, United States. Turf management products for the sports turf industry are produced and distributed, including fertilizers, pesticides, biostimulants, and wetting agents. Formulations in conventional, slow, and controlled-release technologies are available in solid and liquid forms. These are applied across large sports venues and smaller landscaping operations. Technical literature and weather forecasting tools are supplied as additional resources.
- Headquarters Somerset, United States
- Stage Acquired
- SectorsHealthcare
- Website gavispharma.com
- Social LinkedIn
- Acquired by Lupin Pharmaceuticals (Jul 2015)
- Investors
- Acquired byLupin Pharmaceuticals
(Jul 2015)
Investors in Gavis Pharmaceuticals
Gavis Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Lupin Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
APIs, generics, and specialty pharma products are manufactured and marketed. | 1968 | lupinpharmaceuticals.com | Baltimore, United States |
Investor details for Gavis Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Gavis Pharmaceuticals
2 dated milestones of Gavis Pharmaceuticals across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Gavis Pharmaceuticals is founded.
- Exit Acquired by Lupin Pharmaceuticals.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Gavis Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Gavis Pharmaceuticals
Gavis Pharmaceuticals was founded in 2008.
Gavis Pharmaceuticals is headquartered in Somerset, United States.
Gavis Pharmaceuticals was founded in 2008 in Somerset, United States. Turf management products for the sports turf industry are produced and distributed, including fertilizers, pesticides, biostimulants, and wetting agents. Formulations in conventional, slow, and controlled-release technologies are available in solid and liquid forms. These are applied across large sports venues and smaller landscaping operations. Technical literature and weather forecasting tools are supplied as additional resources.
Gavis Pharmaceuticals has 1 investor. Key investors include Lupin Pharmaceuticals.
Yes. Gavis Pharmaceuticals was acquired by Lupin Pharmaceuticals in July 2015.
